Literature DB >> 27178467

A Progenitor Cell Expressing Transcription Factor RORγt Generates All Human Innate Lymphoid Cell Subsets.

Steven D Scoville1, Bethany L Mundy-Bosse2, Michael H Zhang2, Li Chen2, Xiaoli Zhang3, Karen A Keller4, Tiffany Hughes2, Luxi Chen1, Stephanie Cheng4, Stephen M Bergin1, Hsiaoyin C Mao2, Susan McClory5, Jianhua Yu2, William E Carson6, Michael A Caligiuri7, Aharon G Freud8.   

Abstract

The current model of murine innate lymphoid cell (ILC) development holds that mouse ILCs are derived downstream of the common lymphoid progenitor through lineage-restricted progenitors. However, corresponding lineage-restricted progenitors in humans have yet to be discovered. Here we identified a progenitor population in human secondary lymphoid tissues (SLTs) that expressed the transcription factor RORγt and was unique in its ability to generate all known ILC subsets, including natural killer (NK) cells, but not other leukocyte populations. In contrast to murine fate-mapping data, which indicate that only ILC3s express Rorγt, these human progenitor cells as well as human peripheral blood NK cells and all mature ILC populations expressed RORγt. Thus, all human ILCs can be generated through an RORγt(+) developmental pathway from a common progenitor in SLTs. These findings help establish the developmental signals and pathways involved in human ILC development.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27178467      PMCID: PMC4893782          DOI: 10.1016/j.immuni.2016.04.007

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  54 in total

1.  An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation.

Authors:  Nicolas Dulphy; Philippe Haas; Marc Busson; Stéphanie Belhadj; Régis Peffault de Latour; Marie Robin; Maryvonnick Carmagnat; Pascale Loiseau; Ryad Tamouza; Catherine Scieux; Claire Rabian; James P Di Santo; Dominique Charron; Anne Janin; Gérard Socié; Antoine Toubert
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

2.  Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease.

Authors:  J Marius Munneke; Andreas T Björklund; Jenny M Mjösberg; Karin Garming-Legert; Jochem H Bernink; Bianca Blom; Cynthia Huisman; Marinus H J van Oers; Hergen Spits; Karl-Johan Malmberg; Mette D Hazenberg
Journal:  Blood       Date:  2014-05-22       Impact factor: 22.113

3.  Human RORγt(+)CD34(+) cells are lineage-specified progenitors of group 3 RORγt(+) innate lymphoid cells.

Authors:  Elisa Montaldo; Luiz Gustavo Teixeira-Alves; Timor Glatzer; Pawel Durek; Ulrik Stervbo; Wiebke Hamann; Marina Babic; Daniela Paclik; Katharina Stölzel; Jörn Gröne; Laura Lozza; Kerstin Juelke; Nadine Matzmohr; Fabrizio Loiacono; Francesca Petronelli; Nicholas David Huntington; Lorenzo Moretta; Maria Cristina Mingari; Chiara Romagnani
Journal:  Immunity       Date:  2014-11-28       Impact factor: 31.745

4.  Lineage relationships of human interleukin-22-producing CD56+ RORγt+ innate lymphoid cells and conventional natural killer cells.

Authors:  Yong-Oon Ahn; Bruce R Blazar; Jeffrey S Miller; Michael R Verneris
Journal:  Blood       Date:  2013-01-17       Impact factor: 22.113

5.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

Authors:  Mindi R Walker; Deborah J Kasprowicz; Vivian H Gersuk; Angele Benard; Megan Van Landeghen; Jane H Buckner; Steven F Ziegler
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

6.  Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells.

Authors:  Anja Fuchs; William Vermi; Jacob S Lee; Silvia Lonardi; Susan Gilfillan; Rodney D Newberry; Marina Cella; Marco Colonna
Journal:  Immunity       Date:  2013-02-28       Impact factor: 31.745

7.  IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors.

Authors:  Naoko Satoh-Takayama; Sarah Lesjean-Pottier; Paulo Vieira; Shinichiro Sawa; Gerard Eberl; Christian A J Vosshenrich; James P Di Santo
Journal:  J Exp Med       Date:  2010-02-08       Impact factor: 14.307

8.  Different expression of the recombination activity gene RAG-1 in various populations of thymocytes, peripheral T cells and gut thymus-independent intraepithelial lymphocytes suggests two pathways of T cell receptor rearrangement.

Authors:  D Guy-Grand; C Vanden Broecke; C Briottet; M Malassis-Seris; F Selz; P Vassalli
Journal:  Eur J Immunol       Date:  1992-02       Impact factor: 5.532

9.  Transcription factor RORα is critical for nuocyte development.

Authors:  See Heng Wong; Jennifer A Walker; Helen E Jolin; Lesley F Drynan; Emily Hams; Ana Camelo; Jillian L Barlow; Daniel R Neill; Veera Panova; Ute Koch; Freddy Radtke; Clare S Hardman; You Yi Hwang; Padraic G Fallon; Andrew N J McKenzie
Journal:  Nat Immunol       Date:  2012-01-22       Impact factor: 25.606

10.  A committed precursor to innate lymphoid cells.

Authors:  Michael G Constantinides; Benjamin D McDonald; Philip A Verhoef; Albert Bendelac
Journal:  Nature       Date:  2014-02-09       Impact factor: 49.962

View more
  81 in total

Review 1.  Cellular pathways in the development of human and murine innate lymphoid cells.

Authors:  Steven D Scoville; Aharon G Freud; Michael A Caligiuri
Journal:  Curr Opin Immunol       Date:  2018-12-19       Impact factor: 7.486

2.  Insulin-like Growth Factor 1 Supports a Pulmonary Niche that Promotes Type 3 Innate Lymphoid Cell Development in Newborn Lungs.

Authors:  Katherine Oherle; Elizabeth Acker; Madeline Bonfield; Timothy Wang; Jerilyn Gray; Ian Lang; James Bridges; Ian Lewkowich; Yan Xu; Shawn Ahlfeld; William Zacharias; Theresa Alenghat; Hitesh Deshmukh
Journal:  Immunity       Date:  2020-02-18       Impact factor: 31.745

Review 3.  The balance of power: innate lymphoid cells in tissue inflammation and repair.

Authors:  Jim G Castellanos; Randy S Longman
Journal:  J Clin Invest       Date:  2019-06-10       Impact factor: 14.808

Review 4.  Emerging insights into human health and NK cell biology from the study of NK cell deficiencies.

Authors:  Emily M Mace; Jordan S Orange
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 5.  Human innate lymphoid cells (ILCs) in filarial infections.

Authors:  S Bonne-Année; T B Nutman
Journal:  Parasite Immunol       Date:  2017-06-15       Impact factor: 2.280

6.  CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental Pathway.

Authors:  Luxi Chen; Youssef Youssef; Cameron Robinson; Gabrielle F Ernst; Mary Y Carson; Karen A Young; Steven D Scoville; Xiaoli Zhang; Regine Harris; Palak Sekhri; Anthony G Mansour; Wing K Chan; Ansel P Nalin; Hsiaoyin C Mao; Tiffany Hughes; Emily M Mace; Yinghong Pan; Navin Rustagi; Sujash S Chatterjee; Preethi H Gunaratne; Gregory K Behbehani; Bethany L Mundy-Bosse; Michael A Caligiuri; Aharon G Freud
Journal:  Immunity       Date:  2018-09-04       Impact factor: 31.745

Review 7.  Innate Lymphoid Cells: Their Contributions to Gastrointestinal Tissue Homeostasis and HIV/SIV Disease Pathology.

Authors:  Joseph C Mudd; Jason M Brenchley
Journal:  Curr HIV/AIDS Rep       Date:  2019-06       Impact factor: 5.071

Review 8.  The interplay between innate lymphoid cells and T cells.

Authors:  Marie Cherrier; Gayetri Ramachandran; Rachel Golub
Journal:  Mucosal Immunol       Date:  2020-07-10       Impact factor: 7.313

Review 9.  Lineage specification in innate lymphocytes.

Authors:  Arundhoti Das; Christelle Harly; Qi Yang; Avinash Bhandoola
Journal:  Cytokine Growth Factor Rev       Date:  2018-01-12       Impact factor: 7.638

Review 10.  The Broad Spectrum of Human Natural Killer Cell Diversity.

Authors:  Aharon G Freud; Bethany L Mundy-Bosse; Jianhua Yu; Michael A Caligiuri
Journal:  Immunity       Date:  2017-11-21       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.